Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prezista
Marketing
Judge levies $1.64B penalty on J&J in HIV drug marketing case
Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million, a judge has upped the penalty more than tenfold.
Andrea Park
Mar 31, 2025 10:39am
J&J to appeal guilty verdict in $150M HIV false claims case
Jun 17, 2024 12:07pm
After years of buzz, continuous manufacturing is gaining steam
Jun 1, 2021 8:40am
Lexaria posts data on enhancing oral antiviral delivery
Dec 4, 2020 8:53am
J&J warns doctors off using HIV med Prezista for COVID-19
Mar 17, 2020 11:51am
EMA gives nod to Janssen for continuous manufacturing of HIV drug
Jun 27, 2017 8:20am